Indoramin

Chemical formula: C₂₂H₂₅N₃O  Molecular mass: 347.453 g/mol  PubChem compound: 33625

Therapeutic indications

Indoramin is indicated for:

Urinary outflow obstruction due to benign prostatic hyperplasia

Population group: men, only adults (18 - 65 years old)

Management of urinary outflow obstruction due to benign prostatic hyperplasia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary outflow obstruction due to benign prostatic hyperplasia

Population group: only elderly (65 years old or older)

Management of urinary outflow obstruction due to benign prostatic hyperplasia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Indoramin is contraindicated in the following cases:

Heart failure

Cardiac failure

Monoamine oxidase inhibitor

Monoamine oxidase inhibitors (MAOIs)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: DORALESE Film-coated tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈